HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
OFD1
OFD1 centriole and centriolar satellite protein
Chromosome X Β· Xp22.2
NCBI Gene: 8481Ensembl: ENSG00000046651.17HGNC: HGNC:2567UniProt: E9KL37
126PubMed Papers
24Diseases
0Drugs
155Pathogenic Variants
FUNCTIONAL ROLE
Highly Constrained
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
cilium assemblyprotein bindingcentrosomeidentical protein bindingorofaciodigital syndrome IJoubert syndrome 10Simpson-Golabi-Behmel syndrome type 2Joubert syndrome
✦AI Summary

OFD1 is an X-linked centriolar protein essential for primary ciliogenesis and centrosome organization. Functionally, OFD1 regulates centriole length and structure by stabilizing distal centriolar microtubules and promoting distal appendage formation 1. OFD1 recruits intraflagellar transport protein IFT88 to centrioles, enabling cilium assembly 1. The protein functions as a nucleation-promoting factor for Arp2/3 complex-mediated actin branching, linking cytoskeletal dynamics to cell cycle control 2. Mechanistically, OFD1 undergoes PKA-directed ubiquitylation via the TBC1D31/praja2 complex upon GPCR-cAMP stimulation, with proteolysis essential for proper ciliogenesis 3. OFD1 also regulates proteome balance through both proteasomal and autophagic pathways 4. Clinically, OFD1 mutations cause the ciliopathy spectrum ranging from orofaciodigital syndrome type I (X-linked dominant, male-lethal) to Joubert syndrome, primary ciliary dyskinesia, and retinitis pigmentosa 5. The phenotypic variability reflects distinct mutation-dependent effects on centriole elongation 1. Recent findings show OFD1 regulates BRCA1 expression; its inhibition induces BRCAness, creating PARP inhibitor sensitivity in pancreatic cancer 6. Additionally, OFD1 variants associate with autism spectrum disorder on the X chrX 7. Understanding OFD1's multifunctional role improves clinical management and reveals therapeutic opportunities beyond ciliopathies.

Sources cited
1
OFD1 controls centriole length, regulates distal appendage formation, recruits IFT88, and stabilizes centriolar microtubules
PMID: 20230748
2
OFD1 undergoes PKA-directed ubiquitylation via TBC1D31/praja2 complex upon GPCR-cAMP stimulation; this proteolysis is essential for ciliogenesis
PMID: 33934390
3
OFD1 mutations cause diverse phenotypes including orofaciodigital syndrome type I, Joubert syndrome, primary ciliary dyskinesia, and retinitis pigmentosa with different inheritance patterns
PMID: 35112477
4
OFD1 functions as a nucleation-promoting factor for Arp2/3 complex-mediated actin branching and regulates cell cycle progression and ciliogenesis
PMID: 36973243
5
OFD1 controls both protein expression and autophagic/proteasomal degradation, regulating proteome balance in ciliopathies
PMID: 36494254
6
OFD1 regulates BRCA1 expression through E2F4 interaction; OFD1 inhibition induces BRCAness and sensitizes pancreatic cancer to PARP inhibitors
PMID: 40764600
7
OFD1 variants associate with autism spectrum disorder in X-chromosome-wide association studies
PMID: 39706197
8
OFD1 pathogenic variants are associated with primary ciliary dyskinesia, expanding the clinical spectrum of OFD1-related disorders
PMID: 31373179
Disease Associationsβ“˜24
orofaciodigital syndrome IOpen Targets
0.83Strong
Joubert syndrome 10Open Targets
0.80Strong
Simpson-Golabi-Behmel syndrome type 2Open Targets
0.73Strong
Joubert syndromeOpen Targets
0.69Moderate
primary ciliary dyskinesiaOpen Targets
0.68Moderate
Orofaciodigital syndrome type 1Open Targets
0.68Moderate
Joubert syndrome with orofaciodigital defectOpen Targets
0.67Moderate
retinitis pigmentosa 23Open Targets
0.64Moderate
retinitis pigmentosaOpen Targets
0.50Moderate
genetic disorderOpen Targets
0.46Moderate
orofaciodigital syndromeOpen Targets
0.44Moderate
Simpson-Golabi-Behmel syndromeOpen Targets
0.41Moderate
Retinal dystrophyOpen Targets
0.41Moderate
OFD1-related ciliopathyOpen Targets
0.41Moderate
ciliopathyOpen Targets
0.38Weak
eye diseaseOpen Targets
0.37Weak
orofaciodigital syndrome type 6Open Targets
0.37Weak
kidney failureOpen Targets
0.34Weak
Joubert syndrome with hepatic defectOpen Targets
0.33Weak
orofaciodigital syndrome IIIOpen Targets
0.33Weak
Joubert syndrome 10UniProt
Orofaciodigital syndrome 1UniProt
Retinitis pigmentosa 23UniProt
Simpson-Golabi-Behmel syndrome 2UniProt
Pathogenic Variants155
NM_003611.3(OFD1):c.1193_1196del (p.Gln398fs)Pathogenic
not provided|Simpson-Golabi-Behmel syndrome type 2;Orofaciodigital syndrome I;Joubert syndrome 10;Retinitis pigmentosa 23|Orofaciodigital syndrome I|Primary ciliary dyskinesia|Joubert syndrome;Orofaciodigital syndrome I
β˜…β˜…β˜†β˜†2025β†’ Residue 398
NM_003611.3(OFD1):c.2745_2746del (p.Tyr916fs)Pathogenic
Joubert syndrome;Orofaciodigital syndrome I|not provided|Primary ciliary dyskinesia
β˜…β˜…β˜†β˜†2025β†’ Residue 916
NM_003611.3(OFD1):c.1604dup (p.Leu535fs)Pathogenic
Simpson-Golabi-Behmel syndrome type 2;Joubert syndrome 10;Retinitis pigmentosa 23;Orofaciodigital syndrome I|Primary ciliary dyskinesia
β˜…β˜…β˜†β˜†2025β†’ Residue 535
NM_003611.3(OFD1):c.2789_2793del (p.Ile930fs)Pathogenic
Inborn genetic diseases|Joubert syndrome;Orofaciodigital syndrome I|Primary ciliary dyskinesia
β˜…β˜…β˜†β˜†2025β†’ Residue 930
NM_003611.3(OFD1):c.1651_1654del (p.Thr551fs)Pathogenic
Joubert syndrome;Orofaciodigital syndrome I|Kidney failure|OFD1-related ciliopathy
β˜…β˜…β˜†β˜†2025β†’ Residue 551
NM_003611.3(OFD1):c.614_617del (p.Arg205fs)Pathogenic
Orofaciodigital syndrome I|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 205
NM_003611.3(OFD1):c.1365_1368del (p.Lys455fs)Pathogenic
not provided|Orofaciodigital syndrome I|Orofaciodigital syndrome I;Joubert syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 455
NM_003611.3(OFD1):c.2725C>T (p.Arg909Ter)Pathogenic
Orofaciodigital syndrome I;Joubert syndrome|OFD1-related disorder|Primary ciliary dyskinesia|Orofaciodigital syndrome I|Respiratory ciliopathies including non-CF bronchiectasis
β˜…β˜…β˜†β˜†2025β†’ Residue 909
NM_003611.3(OFD1):c.1099C>T (p.Arg367Ter)Pathogenic
Orofaciodigital syndrome I|not provided|Joubert syndrome;Orofaciodigital syndrome I
β˜…β˜…β˜†β˜†2025β†’ Residue 367
NM_003611.3(OFD1):c.400_403del (p.Glu134fs)Pathogenic
Joubert syndrome 10|Simpson-Golabi-Behmel syndrome type 2;Orofaciodigital syndrome I;Joubert syndrome 10|Joubert syndrome;Orofaciodigital syndrome I|not provided|Simpson-Golabi-Behmel syndrome type 2;Orofaciodigital syndrome I;Joubert syndrome 10;Retinitis pigmentosa 23
β˜…β˜…β˜†β˜†2024β†’ Residue 134
NM_003611.3(OFD1):c.710dup (p.Tyr238fs)Pathogenic
not provided|Orofaciodigital syndrome I|Simpson-Golabi-Behmel syndrome type 2;Orofaciodigital syndrome I;Joubert syndrome 10;Retinitis pigmentosa 23|OFD1-related disorder|Simpson-Golabi-Behmel syndrome
β˜…β˜…β˜†β˜†2024β†’ Residue 238
NM_003611.3(OFD1):c.2668C>T (p.Arg890Ter)Pathogenic
Joubert syndrome 10|not provided|Orofaciodigital syndrome I;Joubert syndrome|Retinal dystrophy
β˜…β˜…β˜†β˜†2024β†’ Residue 890
NM_003611.3(OFD1):c.1268_1272del (p.Gln423fs)Pathogenic
OFD1-related disorder|Orofaciodigital syndrome I
β˜…β˜…β˜†β˜†2024β†’ Residue 423
NM_003611.3(OFD1):c.1117_1121del (p.Arg373fs)Pathogenic
Primary ciliary dyskinesia|Joubert syndrome;Orofaciodigital syndrome I
β˜…β˜…β˜†β˜†2024β†’ Residue 373
NM_003611.3(OFD1):c.710del (p.Lys237fs)Pathogenic
Joubert syndrome;Orofaciodigital syndrome I|COACH syndrome|Orofaciodigital syndrome I|OFD1-related disorder
β˜…β˜…β˜†β˜†2023β†’ Residue 237
NM_003611.3(OFD1):c.260A>G (p.Tyr87Cys)Pathogenic
Joubert syndrome;Orofaciodigital syndrome I|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 87
NM_003611.3(OFD1):c.431dup (p.Leu144fs)Pathogenic
Orofaciodigital syndrome I|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 144
NM_003611.3(OFD1):c.538GAT[1] (p.Asp181del)Likely pathogenic
not provided|Joubert syndrome 10
β˜…β˜…β˜†β˜†2023β†’ Residue 181
NM_003611.3(OFD1):c.616_617del (p.Glu206fs)Pathogenic
Joubert syndrome;Orofaciodigital syndrome I|not provided
β˜…β˜…β˜†β˜†2022β†’ Residue 206
NM_003611.3(OFD1):c.1979_1980del (p.Ser660fs)Pathogenic
not provided|Orofaciodigital syndrome I
β˜…β˜…β˜†β˜†2022β†’ Residue 660
View on ClinVar β†—
Related Genes
CC2D2AProtein interaction100%TMEM67Protein interaction99%TMEM216Protein interaction99%ARL13BProtein interaction91%PLK1Protein interaction91%KIF3AProtein interaction90%
Tissue Expression6 tissues
Bone Marrow
100%
Ovary
67%
Lung
36%
Liver
35%
Heart
21%
Brain
15%
Gene Interaction Network
Click a node to explore
OFD1CC2D2ATMEM67TMEM216ARL13BPLK1KIF3A
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt O75665
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.24Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.15 [0.09–0.24]
RankingsWhere OFD1 stands among ~20K protein-coding genes
  • #3,735of 20,598
    Most Researched126 Β· top quartile
  • #491of 5,498
    Most Pathogenic Variants155 Β· top 10%
  • #689of 17,882
    Most Constrained (LOEUF)0.24 Β· top 5%
Genes detectedOFD1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 20301590
1.00
2
OFD1: One gene, several disorders.
PMID: 35112477
Am J Med Genet C Semin Med Genet Β· 2022
0.90
3
PMID: 20301500
0.80
4
The TBC1D31/praja2 complex controls primary ciliogenesis through PKA-directed OFD1 ubiquitylation.
PMID: 33934390
EMBO J Β· 2021
0.70
5
Ofd1, a human disease gene, regulates the length and distal structure of centrioles.
PMID: 20230748
Dev Cell Β· 2010
0.60